about
Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT.Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.Clinical image quality perception and its relation to NECR measurements in PET.Estimating (131)I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification.PET/MR in cancers of the head and neck.Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.Clinical Impact of 68Ga-PSMA PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.PET/MRI and PET/CT in follow-up of head and neck cancer patients.Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.Clinical perspectives of PSMA PET/MRI for prostate cancerPseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatmentNonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findingsImpact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter studyRevisiting Prostate Cancer Recurrence with PSMA PET: Atlas of Typical and Atypical Patterns of SpreadRegorafenib in Patients with Antiangiogenic-Naïve and Chemotherapy-Refractory Advanced Colorectal Cancer: Results from a Phase IIb TrialAberrant Hypermetabolism of Benign Uterine Leiomyoma on 18F-FDG PET/CTDiagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients
P50
Q35683973-0992336D-4523-4EA9-A9FA-E966302BC4A7Q35877119-E01F4B98-9217-445D-83A7-AF843B302B11Q35986417-D65EC43A-AF29-49E5-A980-8A85E44FEAEEQ37079244-F3397DCB-2C32-46A4-A82E-8D7096C76D6CQ38405103-5C6B296F-9DD6-4C2F-8DA1-0B3EAC408234Q39276430-1CE7FE7E-8DC2-4751-ADCC-B484C4AF6787Q40511033-12957E30-3557-4BC9-B4D6-799C49DA1783Q51713748-347E0E47-3E49-43F1-A83B-C95689FAF72FQ51737141-69BCFF5C-6FBA-4BF7-87F8-AE2D93688E70Q52982457-69789FC2-0157-47D9-B6D3-84BC3693DCC4Q53006808-B37097B5-1CD9-4F9E-A7BF-784DFEE2C12EQ53057576-E144BAE7-3F1B-431F-8964-5A6424C7DD06Q53077440-DE564564-94F9-4ADD-A7C3-7F01DB80CA96Q53609093-82524FCF-1A6F-4AE4-B486-E73E1C5AB465Q57071079-CA4B707B-5B26-4BD4-8BCD-F26BAF81D39EQ90219334-E4B43E1E-4A6A-405B-BB75-D13136A5F01EQ90310413-98EBBC39-1FC9-421F-84D2-2ED1FFEC5104Q90833979-2A797C27-E898-423D-945D-C471850D101DQ90942942-D2369DE6-65C3-44CE-B9B5-645E2EC7C050Q92595107-35E9450C-0DAC-42D3-A36B-E2D47AD16F8BQ93094333-0030B72B-C8B2-4523-9DD8-F2BD8A122EE8Q96610432-6D0DA076-3A54-4DED-BA7F-3CE2A85C92AF
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Marcelo Queiroz
@ast
Marcelo Queiroz
@en
Marcelo Queiroz
@es
Marcelo Queiroz
@nl
type
label
Marcelo Queiroz
@ast
Marcelo Queiroz
@en
Marcelo Queiroz
@es
Marcelo Queiroz
@nl
altLabel
MA Queiroz
@en
prefLabel
Marcelo Queiroz
@ast
Marcelo Queiroz
@en
Marcelo Queiroz
@es
Marcelo Queiroz
@nl
P106
P21
P31
P496
0000-0003-0052-0682